Balyasny Asset Management
VMD icon

Balyasny Asset Management’s Viemed Healthcare VMD Stock Holding History

Balyasny Asset Management’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-13,861
Closed -$134K – 2833
2023
Q1 		$134K Sell
13,861
-7,382
-35% -$64.4K ﹤0.01% 2286
2022
Q4 		$161K Buy
+21,243
New +$144K ﹤0.01% 2174

Other funds holding VMD

Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $201M AUM 9.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TPM
Triasima Portfolio Management Montreal, Quebec, Canada $661M AUM 63.05% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Balyasny Asset Management's VMD Position: Q2 2023 in Review

Balyasny Asset Management sold out of Viemed Healthcare (VMD) in Q2 2023, closing a stake of 13,861 shares — an estimated $134K sold.

Balyasny Asset Management first reported a position in VMD in Q4 2022 and held it in 2 quarters. The position peaked at $161K in Q4 2022. 103 funds tracked by Wall St. Rank hold VMD as of Q2 2023.

  • Balyasny Asset Management reported no remaining Viemed Healthcare position as of Q2 2023 after selling out during the quarter.
  • Balyasny Asset Management sold 13,861 Viemed Healthcare shares in Q2 2023, an estimated $134K.
  • Balyasny Asset Management first reported a position in Viemed Healthcare in Q4 2022 and held it in 2 quarters.
  • Balyasny Asset Management's Viemed Healthcare position peaked at $161K in Q4 2022.
  • 103 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2023.

Based on Balyasny Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.